Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.

Source:http://linkedlifedata.com/resource/pubmed/id/17980251

J. Am. Coll. Cardiol. 2007 Nov 6 50 19 1852-6

Download in:

View as

Triples

General Info

PMID
17980251